GLOBAL PHARMACEUTICAL MARKET TRENDS: OPPORTUNITIES FOR DEVELOPMENT

GLOBAL PHARMACEUTICAL MARKET TRENDS: OPPORTUNITIES FOR DEVELOPMENT

Global medicine spending will reach nearly $1.12 trillion by 2022 on an invoice price basis, up nearly $370 billion from the 2016 estimated spending level. Current trends are based on disruptive technologies including gene-editing, precision medicines and digital technologies, Big Data etc. The char...

Full description

Bibliographic Details
Main Authors:	D. A. Demidyonok, T. A. Petrova, I. A. Narkevich, V. A. Markova
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	global pharmaceutical market personalized (precision) medicine big data biotechnology biopharmaceuticals orphan drugs disruptive technologies
Online Access:	https://www.pharmjournal.ru/jour/article/view/529

Similar Items

Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators
by: Rezaie Rahim, et al.
Published: (2012-06-01)

Strategic aspects of staffing industrial biopharmaceutical companies
by: A. S. Glazkova, et al.
Published: (2020-01-01)

Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s)
by: Hao Hu, et al.
Published: (2015-12-01)

Pharmaceutical Opportunities : A three-step repositioning model for evaluating market options
by: SANDMAN, SARA
Published: (2016)

Editorial: Pharmaceutical Innovation After World War II: From Rational Drug Discovery to Biopharmaceuticals
by: Apostolos Zarros, et al.
Published: (2019-07-01)

Prospective of Transformation of Current Models of the Global Pharmaceutical Market
by: Yuriy Solodkovskyy, et al.
Published: (2012-02-01)

Expenditure trends of orphan drugs in Serbia: 8-Year analysis of orphan drug market in Serbia
by: Pejčić Ana V., et al.
Published: (2016-01-01)

Biotechnology: employing organism as bioreactors
by: Maryam Baniasad, et al.
Published: (2015-06-01)

General characteristics of top 100 selling drugs: Turkish pharmaceutical market between 2003 and 2016
by: Guven Bektemur, et al.
Published: (2018-09-01)

Pharmaceutical Innovation After World War II: From Rational Drug Discovery to Biopharmaceuticals
Published: (2019)

Brief Note on the Development of Biotechnology
by: Karl Bayer
Published: (2014-01-01)

Corporate Social Responsibility (CSR) of Innovative Pharmaceutical Corporations. The Case of BIOGEN
by: Janina Witkowska
Published: (2018-09-01)

Plastid transformation: Advances and challenges for its implementation in agricultural crops
by: Quintín Rascón-Cruz, et al.
Published: (2021-05-01)

Marine Biotechnology: Challenges and Development Market Trends for the Enhancement of Biotic Resources in Industrial Pharmaceutical and Food Applications. A Statistical Analysis of Scientific Literature and Business Models
by: Sara Daniotti, et al.
Published: (2021-01-01)

European and Italian regulation on orphan medicinal products
by: Roberta Joppi
Published: (2013-03-01)

Challenges of Pharmacoeconomics in Global Health Arena
Published: (2019)

The Potential Benefit of Expedited Development and Approval Programs in Precision Medicine
by: Ariel Kantor, et al.
Published: (2021-01-01)

Resilience strategies and the pharmaceutical supply chain: the role of agility in mitigating drug shortages
by: Yaroson, Emilia V., et al.
Published: (2020)

Prospects and Trends in the Brazilian Market for Biologically Sourced Products
by: Luciana da Silva Madeira, et al.
Published: (2012-09-01)

Digital Twins in Pharmaceutical and Biopharmaceutical Manufacturing: A Literature Review
by: Yingjie Chen, et al.
Published: (2020-09-01)

How Scientist/Founders Lead Successful Biopharmaceutical Organizations: A Study of Three Companies
by: Langer, Lynn Johnson
Published: (2008)

Cell-surface glycan-lectin interactions for biomedical applications

Pharmaceuticals Market, Consumption Trends and Disease Incidence Are Not Driving the Pharmaceutical Research on Water and Wastewater
by: Omar Israel González Peña, et al.
Published: (2021-03-01)

Using four decades of FDA orphan drug designations to describe trends in rare disease drug development: substantial growth seen in development of drugs for rare oncologic, neurologic, and pediatric-onset diseases
by: Kathleen L. Miller, et al.
Published: (2021-06-01)

Optimising a launch : Important factors affecting a new pharmaceutical launch in Sweden
by: Smedsrud, Sabina, et al.
Published: (2019)

Biopharmaceuticals from microorganisms: from production to purification
by: Angela Faustino Jozala, et al.

Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases
by: V. Vanhoorne, et al.
Published: (2019-08-01)

Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status
by: N. Maniadakis, et al.
Published: (2017-05-01)

PHARMACEUTICAL DEVELOPMENT OF DRUGS FOR PEDIATRIC PRACTICE: FUNDAMENTAL BASES AND SPECIFIC FEATURES
by: I. A. Narkevich, et al.
Published: (2019-01-01)

Pharmaceutical value chain: opportunities for outsourcing
by: Natalia A. Volgina
Published: (2021-12-01)

The Transporter-Mediated Cellular Uptake and Efflux of Pharmaceutical Drugs and Biotechnology Products: How and Why Phospholipid Bilayer Transport Is Negligible in Real Biomembranes
by: Douglas B. Kell
Published: (2021-09-01)

COVID-19 Crisis: How Can Plant Biotechnology Help?
by: M. J. I. Shohag, et al.
Published: (2021-02-01)

Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!
by: Thomas Sécher, et al.
Published: (2019-11-01)

PHARMACEUTICAL DEVELOPMENT OF FORMULATION BASED ON BIOPHARMACEUTICAL PREPARATIONS FOR GENE THERAPY
by: T. V. Budylskaya, et al.
Published: (2019-01-01)

Biosimilars in rheumatology and other fields of medicine
by: Marcin Milchert, et al.
Published: (2014-07-01)

Prodrugs for Improved Drug Delivery: Lessons Learned from Recently Developed and Marketed Products
by: Milica Markovic, et al.
Published: (2020-10-01)

Analysis of patient access to orphan drugs in Turkey
by: Güvenç Koçkaya, et al.
Published: (2021-02-01)

Precision Medicine and Global Health: The Good, the Bad, and the Ugly
by: Alexios-Fotios A. Mentis, et al.
Published: (2018-03-01)

Editorial: Synthesis, Functionalization, and Clinical Translation of Pharmaceutical Biomaterials
by: Huimin Kong, et al.
Published: (2021-06-01)

Corrigendum: Precision Medicine and Global Health: The Good, the Bad, and the Ugly
by: Alexios-Fotios A. Mentis, et al.
Published: (2018-04-01)